A new study suggests that extending colorectal cancer screening intervals from 2 to 3 years may be feasible for low-risk individuals.
In my 40 years as a healthcare professional, I have seen firsthand the importance of staying informed about our health and on top of preventive screening.
A correspondence says prospective studies support Galleri’s ability to detect clinically important cancers earlier, although ...
Ryan Moore, MD, discusses the choice between surgery and total neoadjuvant therapy (TNT) for rectal cancer and when watch-and ...
Capsule-sponge DNA methylation test boosts Barrett’s screening access, showing high accuracy, strong tolerability, and ...
Geneoscopy, Inc., a healthcare diagnostics company advancing the next generation of tools for gastrointestinal health, today announced the launch of ColoSense NextStep, a provider-enabled, opt-in ...
The FDA just approved Jemperli for some adults with locally advanced rectal cancer, offering an effective immunotherapy ...
Abbott, a global healthcare leader, announced today that the Cologuard Plus® test has received CE Mark under the European Union's In Vitro Diagnostic Medical Devices Regulation (IVDR), marking an impo ...
Summary of Yesterday's Market Trends]In yesterday's commodity market, grains and other agricultural products fell, while ...
Guardant Health (NDQ:GH) reckons it has a better way of screening for cancers other than colonoscopies and faecal tests. Both ...
Critics Consensus: Avatar Aang is a glowing continuation of The Last Airbender series, giving audiences an audacious update to their favorite characters while being technically proficient and visually ...
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results